Simplex Trading’s Checkpoint Therapeutics CKPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-900
| Closed | -$3K | – | 8747 |
|
|
2025
Q1 | $3K | Sell |
900
-22,000
| -96% | -$73.3K | ﹤0.01% | 7787 |
|
|
2024
Q4 | $73K | Buy |
22,900
+17,900
| +358% | +$60.7K | ﹤0.01% | 5479 |
|
|
2024
Q3 | $11K | Sell |
5,000
-2,000
| -29% | -$4.62K | ﹤0.01% | 7115 |
|
|
2024
Q2 | $15K | Sell |
7,000
-5,700
| -45% | -$10.1K | ﹤0.01% | 7115 |
|
|
2024
Q1 | $26K | Sell |
12,700
-13,300
| -51% | -$26.5K | ﹤0.01% | 6859 |
|
|
2023
Q4 | $59K | Buy |
26,000
+24,500
| +1,633% | +$53.3K | ﹤0.01% | 5927 |
|
|
2023
Q3 | $2K | Sell |
1,500
-5,000
| -77% | -$11.4K | ﹤0.01% | 8053 |
|
|
2023
Q2 | $16K | Sell |
6,500
-30,200
| -82% | -$82.5K | ﹤0.01% | 6962 |
|
|
2023
Q1 | $82K | Buy |
36,700
+34,700
| +1,735% | +$174K | ﹤0.01% | 5374 |
|
|
2022
Q4 | $10K | Buy |
2,000
+1,120
| +127% | +$8.07K | ﹤0.01% | 7517 |
|
|
2022
Q3 | $9K | Sell |
880
-4,540
| -84% | -$54.1K | ﹤0.01% | 8303 |
|
|
2022
Q2 | $55K | Sell |
5,420
-2,400
| -31% | -$31.4K | ﹤0.01% | 6359 |
|
|
2022
Q1 | $138K | Buy |
7,820
+6,100
| +355% | +$131K | ﹤0.01% | 5688 |
|
|
2021
Q4 | $53K | Buy |
1,720
+440
| +34% | +$14.6K | ﹤0.01% | 7185 |
|
|
2021
Q3 | $37K | Hold |
1,280
| – | – | ﹤0.01% | 7875 |
|
|
2021
Q2 | $37K | Buy |
1,280
+1,279
| +127,900% | +$35.4K | ﹤0.01% | 7990 |
|
|
2021
Q1 | $1K | Buy |
+1
| New | +$34 | ﹤0.01% | 8539 |
|
Simplex Trading's CKPT Position: Q1 2024 in Review
Simplex Trading sold out of Checkpoint Therapeutics (CKPT) in Q1 2024, closing a stake of 13,611 shares — an estimated $27.2K sold.
Simplex Trading first reported a position in CKPT in Q1 2021 and held it in 9 quarters. The position peaked at $334K in Q4 2021. 40 funds tracked by Wall St. Rank hold CKPT as of Q1 2024.
- Simplex Trading reported no remaining Checkpoint Therapeutics position as of Q1 2024 after selling out during the quarter.
- Simplex Trading sold 13,611 Checkpoint Therapeutics shares in Q1 2024, an estimated $27.2K.
- Simplex Trading first reported a position in Checkpoint Therapeutics in Q1 2021 and held it in 9 quarters.
- Simplex Trading's Checkpoint Therapeutics position peaked at $334K in Q4 2021.
- 40 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q1 2024.
Based on Simplex Trading's 13F filing for Q1 2024, filed 25 Apr 2024.